Table 1. Demographics of characteristics of 2570 participants who underwent HPV testing in South East District, Botswana stratified by HIV status.
| Characteristic | Women with HIV | Women without HIV | ||
| 30–49 (n=1035) | 50+ (n=328) | 30–49 (n=888) | 50+ (n=319) | |
| Age, years±SD | 40.7±5.3 | 56.5±5.4 | 38.9±5.5 | 58.6±6.4 |
| Education | ||||
| ≤Primary | 120 (11.6) | 192 (58.5) | 50 (5.6) | 195 (61.1) |
| ≥Secondary | 914 (88.4) | 136 (41.5) | 838 (94.4) | 124 (38.9) |
| Employed | 611 (59.0) | 167 (50.9) | 559 (63.0) | 138 (43.3) |
| Marital status | ||||
| Single | 810 (78.3) | 188 (57.3) | 619 (69.7) | 137 (43.0) |
| Married | 198 (19.1) | 79 (24.1) | 249 (28.0) | 125 (39.2) |
| Divorced/separated | 12 (1.2) | 8 (2.4) | 10 (1.1) | 8 (2.5) |
| Widowed | 15 (1.5) | 53 (16.2) | 10 (1.1) | 49 (15.4) |
| Gravidity | ||||
| 0 | 57 (5.5) | 7 (2.1) | 45 (5.1) | 3 (0.9) |
| 1–3 | 676 (65.3) | 162 (49.4) | 621 (69.9) | 139 (43.6) |
| ≥4 | 302 (29.2) | 159 (48.5) | 222 (25.0) | 177 (55.5) |
| Parity | ||||
| 0 | 65 (6.3) | 14 (4.3) | 54 (6.1) | 4 (1.3) |
| 1–3 | 745 (72.0) | 175 (53.4) | 686 (77.3) | 153 (48.0) |
| ≥4 | 225 (21.7) | 139 (42.4) | 148 (16.7) | 162 (50.8) |
| Premenopausal | 929 (89.8) | 26 (7.9) | 832 (93.7) | 34 (10.7) |
| Age of sexual debut, years±SD | 19.2±2.7 | 19.0±2.4 | 19.5±2.8 | 19.0±2.6 |
| Lifetime sexual partners* | ||||
| 0 | 0 (0.0) | 0 (0.0) | 2 (0.2) | 0 (0.0) |
| 1–5 | 609 (59.0) | 227 (70.1) | 593 (66.9) | 259 (82.0) |
| ≥6 | 424 (41.1) | 97 (29.9) | 291 (32.8) | 57 (18.0) |
| Smoking | 71 (6.9) | 28 (8.5) | 29 (3.3) | 12 (3.8) |
| History of cervical screening† | 842 (81.4) | 268 (81.7) | 535 (60.3) | 203 (63.6) |
| History of abnormal cervical screening | ||||
| Normal | 747 (88.7) | 231 (86.2) | 431 (80.6) | 170 (83.7) |
| Abnormal | 29 (3.4) | 9 (3.4) | 10 (1.9) | 8 (3.9) |
| Not sure | 66 (7.8) | 28 (10.5) | 94 (17.6) | 25 (12.3) |
| History of ablation procedure‡ | 6 (20.7) | 0 (0.0) | 3 (30.0) | 0 (0.0) |
| History of cervical excisional procedure‡ | 12 (1.2) | 4 (1.2) | 5 (0.6) | 2 (0.6) |
| Duration of HIV diagnosis, years±SD | 9.6±5.5 | 12.4±5.3 | – | – |
| Currently on ART | 1034 (99.9) | 328 (100.0) | – | – |
| Length of time on ART, years±SD | 8.0±5.1 | 10.4±5.4 | – | – |
| CD4 count (per µL) | ||||
| <200 | 19 (1.8) | 4 (1.2) | – | – |
| 200–500 | 203 (19.6) | 64 (19.5) | – | – |
| >500 | 813 (78.6) | 260 (79.3) | – | – |
| Detectable viral load | 10 (1.0) | 2 (0.6) | – | – |
| High-risk HPV positive | 558 (53.9) | 187 (57.0) | 377 (42.5) | 134 (42.0) |
*
Missing data: 1 participant missing education, 11 missing number of sexual partners, and 1 missing viral load.
†
Self-reported.
‡
Among those who reported an abnormal cervical screen.
ART, antiretroviral therapy; HPVhuman papillomavirusVIA, visual inspection with acetic acid